Oosterwijk-Wakka, Jeannette C <br/><br/>
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 500-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Standard No.: </label>10.1097/00002371-200211000-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Antibodies, Neoplasm--biosynthesis<br/>Antigens, Neoplasm--immunology<br/>Cancer Vaccines--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Differentiation<br/>Combined Modality Therapy<br/>Dendritic Cells--immunology<br/>Feasibility Studies<br/>Follow-Up Studies<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Humans<br/>Hypersensitivity, Delayed--immunology<br/>Immunization Schedule<br/>Immunologic Memory<br/>Immunophenotyping<br/>Interferon-gamma--metabolism<br/>Interleukin-2--therapeutic use<br/>Interleukin-4--pharmacology<br/>Kidney Neoplasms--drug therapy<br/>Lymphocyte Activation<br/>Lymphocyte Subsets--immunology<br/>Monocytes--cytology<br/>Nephrectomy<br/>Recombinant Proteins--pharmacology<br/>Treatment Outcome<br/>Vaccination